CytoLogic
Boulder
About CytoLogic
CytoLogic, Inc., a medical device company, focuses on developing and commercializing a technology for treating cancerous tumors. The company’s UNLEASH therapy, which engages selective filtration of blood plasma on a dialysis-type platform, enhances a cancer patient’s natural immune response to malignant cells. Its UNLEASH technology depletes certain inhibitors of the body’s immune function enabling the patient’s immune system to fight malignant tumors. CytoLogic was founded in 1998 and is based in Boulder, Colorado.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $978.6K
- Last round: Series Unknown (Jun 2012)
- Website: cytologic.com
- Phone: 605-431-6723
Industries & Categories
Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/cytologic-2862923 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.